Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - MYRIAD GENETICS INC | mygn-ex321_6.htm |
| EX-31.2 - EX-31.2 - MYRIAD GENETICS INC | mygn-ex312_7.htm |
| EX-31.1 - EX-31.1 - MYRIAD GENETICS INC | mygn-ex311_8.htm |
| EX-10.1 - EX-10.1 - MYRIAD GENETICS INC | mygn-ex101_186.htm |
| 10-Q - 10-Q - MYRIAD GENETICS INC | mygn-10q_20170930.htm |
Exhibit 10.2
Attachment
Each of the following directors and executive officers of Myriad Genetics, Inc. has entered into the Company’s standard form Indemnification Agreement.
|
Directors and Executive Officer |
Execution Date |
|
John T. Henderson, M.D., Chairman of the Board |
June 02, 2009 |
|
Walter Gilbert, Ph.D., Vice Chairman of the Board |
June 02, 2009 |
|
Lawrence C. Best, Director |
September 16, 2009 |
|
Heiner Dreismann, Ph.D., Director |
September 16, 2010 |
|
Dennis H. Langer, M.D., J.D., Director |
June 02, 2009 |
|
S. Louise Phanstiel, Director |
September 16, 2009 |
|
Mark C. Capone, President and Chief Executive Officer |
June 16, 2009 |
|
Alexander Ford, President, Myriad Genetic Laboratories, Inc. |
July 01, 2015 |
|
Gary A. King, EVP International Operations |
June 13, 2013 |
|
Jerry S. Lanchbury, Ph.D., Chief Scientific Officer |
June 16, 2009 |
|
Richard M. Marsh, Esq., EVP, General Counsel and Secretary |
June 16, 2009 |
|
Ralph L. McDade, President, Myriad RBM, Inc. |
June 05, 2014 |
|
R. Bryan Riggsbee, Chief Financial Officer and Treasurer |
February 23, 2015 |
|
Bernard F. Tobin, President, Crescendo Biosciences, Inc. |
February 23, 2015 |
|
Mark Verratti, President, Assurex Health, Inc. |
September 19, 2017 |